University of Michigan Nephrology Research BioBank
Michigan Nephrology Research BioBank for Molecular Analysis of Renal Disease Nephrology Research BioBank
Sponsor: Regeneron Pharmaceuticals
A observational or N/A phase clinical study on Chronic Kidney Disease, this trial is actively recruiting participants. The trial is conducted by Regeneron Pharmaceuticals and has accumulated 17 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
17 versions recorded-
May 2025 — Present [monthly]
Recruiting
-
Sep 2024 — May 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Jun 2024 — Jul 2024 [monthly]
Recruiting
-
Feb 2024 — Jun 2024 [monthly]
Recruiting
▶ Show 12 earlier versions
-
Mar 2023 — Feb 2024 [monthly]
Recruiting
-
Jan 2022 — Mar 2023 [monthly]
Recruiting
-
Dec 2021 — Jan 2022 [monthly]
Recruiting
-
Jan 2021 — Dec 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Nov 2019 — Nov 2020 [monthly]
Recruiting
-
Nov 2018 — Nov 2019 [monthly]
Recruiting
-
Jun 2018 — Nov 2018 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Sep 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Regeneron Pharmaceuticals
- University of Michigan
- amfAR, The Foundation for AIDS Research
For direct contact, visit the study record on ClinicalTrials.gov .